supported by the National Natural Science Foundation of China (Grant No. 30672208, 81270603, and 31301161);Tianjin Natural Science Foundation of China (Grant No. 13JCYBJC22800)
Objective: To investigate the effects of CAL-101, particularly when combined with bortezomib(BTZ) on mantle cell lymphoma(MCL) cells, and to explore its relative mechanisms.Methods: MTT assay was applied to detect the...